X

Martin Shkreli Now Praising Kids Who Made Cheap Drug

He makes congratulatory video after belittling their work on Twitter
By Jenn Gidman,  Newser Staff
Posted Dec 2, 2016 12:42 PM CST

(Newser) – A bunch of Aussie schoolkids produced a $2-a-pill version of a super-expensive anti-parasitic drug ($750 per dose), and the man behind the latter drug's huge price hike is now praising their efforts, Reuters reports. In a YouTube video directed toward students at Sydney Grammar School, ex-Turing Pharmaceuticals CEO Martin Shkreli says he's "delighted" that students are increasingly entering STEM fields and offers congratulations to this specific group, saying they're "proof that the 21st-century economy will solve problems of human suffering through science and technology." He also praises his own inventing efforts. "Not long ago I was an enterprising young scientist student," he says, talking up what he says has been the success of a clinical trial he started at NYU, as well as a medicine he says he invented that's soon to enter clinical trials.

story continues below

It's a bit of a turnaround from his earlier take on the story, when he posted a snarky comment on Twitter Wednesday about the kids' accomplishment, followed by another eye-rolling post on Thursday. "These kids who 'made Daraprim' (remind) me of Ahmed who 'made the clock'. Dumb journalists want a feel good story," he tweeted. One of the students tells the Australia version of the Guardian that they were able to use "simple school-available chemicals" to upend Shkreli's "overpriced method" and that he's just an "attention-seeking businessman." Meanwhile, Quartz delves into the legalities of why Daraprim remains so costly if a bunch of schoolkids can produce it on the cheap, observing, "Sadly, barring Shkreli's lack of nuance, he does have a point." (Shkreli fulfilled a musical promise after Donald Trump's victory.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
X